Antonio Cusmai

982 citations
28 papers · 577 indexed · h-index 11
Topics
Cancer Immunotherapy and Biomarkers (9 papers)HER2/EGFR in Cancer Research (6 papers)Immunotherapy and Immune Responses (5 papers)
Partner nations
ItalyTürkiyeSpain

In The Last Decade

Antonio Cusmai

27 papers receiving 569 citations

Peers

Antonio Cusmai
Comparison fields: 5 of 64
  • Oncology 292
  • Molecular Biology 197
  • Immunology 138
  • Hematology 126
  • Pulmonary and Respiratory Medicine 124
Replace Christoph Heining with:
Christoph Heining Germany
Ian Mak United Kingdom
Hong Xie United States
M. Durante United States
Valérie Méresse France
Monika Haemmerle Germany
Rita Ruijter Netherlands
Christopher Riley United States
Marielle Chiron France
Paul A. Algate United States
Antonio Cusmai relative to Christoph Heining Germany Christoph Heining's profile →
Citations per field
00.5×3.6×
Christoph Heining · 1×
Citations per year

Countries citing papers authored by Antonio Cusmai

Since Specialization
Citations

This map shows the geographic impact of Antonio Cusmai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Cusmai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Cusmai more than expected).

Fields of papers citing papers by Antonio Cusmai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Cusmai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Cusmai. The network helps show where Antonio Cusmai may publish in the future.

Co-authorship network of co-authors of Antonio Cusmai

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Cusmai. A scholar is included among the top collaborators of Antonio Cusmai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Cusmai. Antonio Cusmai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 9
3 1
4 2
5 1
6 4
7 9
8 72
9 5
10 3
11 82
12 52
13 2
14 0
15 20
16 20
17 13
18 29
19 127
20 69

About Antonio Cusmai

Antonio Cusmai is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 577 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), HER2/EGFR in Cancer Research (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Hematology (126 citations), Oncology (292 citations) and Cancer Research (109 citations). Antonio Cusmai has collaborated with scholars based in Italy, Türkiye and Spain. Frequent co-authors include Franco Dammacco, Maria Antonia Frassanito, Alessandro Rizzo, Gennaro Palmiotti, Giuseppe Iodice, Gennaro Gadaleta‐Caldarola, Silvana Acquafredda, L. Rinaldi, A. Misino and Elisabetta Montagna. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026